2017 Year in Review: Top 10 News Stories

Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic cancer research, national news, volunteer contributions and more. Keep an eye out for more of the articles on our blog until the end of December.

For the pancreatic cancer community, this was a year of unforeseen breakthroughs, hard-fought lessons and heartbreaking inspiration. Here are our top 10 most-viewed news stories from 2017.

FDA Approval of Keytruda Drug
Historic announcement of the first cancer drug approved by the FDA for the treatment of solid tumors based on their molecular profile.